Gilead to pay $97 million to resolve kickback claims -U.S. Justice Department
WASHINGTON, Sept 23 (Reuters) - Gilead Sciences Inc GILD.O has agreed to pay $97 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug Letairis, the Justice Department said on Wednesday.
(Reporting by Mohammad Zargham)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In This StoryGILD
Latest Markets Videos
- US STOCKS-Wall St plunges as Snap's bleak forecast sparks selloff
- All Fed officials backed May rate hike, 'most' saw half-point rises in June and July, minutes show
- US STOCKS-Wall Street surges on upbeat retail guidance, easing Fed fears
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard